Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
Newsletter opened	Fri, 08/14/2020 - 06:58	Opened		Анонимен
Newsletter opened	Fri, 08/14/2020 - 06:08	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Newsletter de Progress in Mind España		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Japan newsletter		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Thu, 08/13/2020 - 19:14	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
Newsletter opened	Fri, 08/14/2020 - 06:58	Opened		Анонимен
Newsletter opened	Fri, 08/14/2020 - 06:08	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Newsletter de Progress in Mind España		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Japan newsletter		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Thu, 08/13/2020 - 19:14	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER